Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Efficacy of Vosevi in Treating DAA-experienced Patients — Stella

Home/Chronic Hepatitis C/The Efficacy of Vosevi in Treating DAA-experienced Patients

View on ClinicalTrials.gov

Recruiting

Back to Chronic Hepatitis C trials

The Efficacy of Vosevi in Treating DAA-experienced Patients

Trial locations(1 site)

China

The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong

Key details

Sponsor

The Third Affiliated Hospital of Guangzhou Medical University

Enrollment target

~200 participants

Started

February 2023

Primary completion

February 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

20 Years – 70 Years

Last updated March 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.